Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)
Clinical trial NCT05203341 · COMPLETED
Trial details
- NCT number
- NCT05203341
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-21
- Primary completion
- 2024-01-10
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.